Lymphocytic choriomeningitis virus. II. Characterization of extractable complement-fixing activity.
Lymphocytic choriomeningitis (LCM) virus-specific complement-fixing (CF) antigen (ECFA) has been solubilized, concentrated, and partially purified. When inoculated together with Freund's adjuvant, ECFA induced CF antibody but not neutralizing antibody or protective immunity. By itself it boosted pre-existing CF antibody but no neutralizing antibody. In double diffusion tests one line developed between ECFA and its antiserum, and a corresponding line became visible when ECFA interacted with an antiserum directed against all LCM virus-specific antigens. Absorption of either serum with ECFA abolished all ECFA-precipitating qualities. Ouchterlony tests also revealed that ECFA prepared from cells and tissues of various species is immunologically identical. By a variety of procedures ECFA was not found to be represented on the surface of either the virion or the infected cell. When purified infectious LCM virus was disrupted, a CF antigen corresponding immunologically to ECFA was set free. In double diffusion tests this antigen gave a line of identity with ECFA. Thus, ECFA appears to be an internal component of the infectious LCM virus.
D000818:Animals; D000937:Antigen-Antibody Reactions; D000956:Antigens, Viral / Q000302:isolation & purification*; D003165:Complement System Proteins / Q000302:isolation & purification*; D005455:Fluorescent Antibody Technique; D005620:Freund's Adjuvant; D006168:Guinea Pigs; D007106:Immune Sera; D005779:Immunodiffusion; D066298:In Vitro Techniques; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology*; D051379:Mice; D009500:Neutralization Tests; D011817:Rabbits
D000956:Antigens, Viral; D007106:Immune Sera; D003165:Complement System Proteins; D005620:Freund's Adjuvant